<DOC>
	<DOCNO>NCT00060021</DOCNO>
	<brief_summary>RATIONALE : Acupuncture may effective relieve mucositis-related pain cause chemotherapy patient undergoing stem cell transplantation . PURPOSE : Randomized clinical trial study effectiveness acupuncture treat mucositis-related pain cause high-dose chemotherapy patient undergoing stem cell transplantation .</brief_summary>
	<brief_title>Acupuncture Treating Mucositis-Related Pain Caused Chemotherapy Patients Undergoing Stem Cell Transplantation</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy acupuncture v placebo acupuncture alleviate mucositis-related pain secondary high-dose chemotherapy , assess total cumulative dose opioids use subjective pain score , patient undergo hematopoietic stem cell transplantation . - Compare overall number patient require opioid therapy 2 intervention group . - Compare nausea vomit score patient 2 intervention group . - Compare sedation score patient 2 intervention group . - Compare use psychotropic medication ( e.g. , anxiolytic hypnotic ) patient 2 intervention group . - Compare need total parenteral nutrition ( TPN ) number day TPN experience patient 2 intervention group . - Compare pruritus need symptomatic treatment patient 2 intervention group . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients stratify accord 9-phenylthiocarbamide/6-n-propylthiouracil ( PROP ) taste ability ( super-tasters v non-super-tasters ) . Patients randomize 1 2 treatment arm . - Arm I : Beginning immediately development mucositis pain , patient undergo acupuncture 30 minute daily . Patients also receive standard pain management . Treatment continue pain completely resolve absence unacceptable toxicity . - Arm II : Patients undergo placebo acupuncture receive standard pain management arm I . PROJECTED ACCRUAL : A maximum 45 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Must undergo hematopoietic stem cell transplantation ( HSCT ) one follow mean : Concurrent enrollment HSCT protocol Experimental Transplantation &amp; Immunology Branch ( ETIB ) NCI Center Clinical Research* Receiving HSCT compassionate exemption follow clinical guideline ETIB protocol* Directly observe oral pharyngeal mucositis and/or suspect esophageal mucositis highdose chemotherapy No pain unrelated mucositis require use potent analgesic prior initiation highdose chemotherapy NOTE : *Protocol must know generate 50 % incidence highdose chemotherapyinduced mucositis PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy Not specify Hematopoietic No history bleed disorder Hepatic PT PTT normal Renal Not specify Other No history evidence drug addiction drugseeking behavior No skin infection sit acupuncture point PRIOR CONCURRENT THERAPY : Biologic therapy See Disease Characteristics Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other No concurrent anticoagulant therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>oral complication</keyword>
	<keyword>pain</keyword>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>chronic eosinophilic leukemia</keyword>
	<keyword>primary myelofibrosis</keyword>
	<keyword>chronic neutrophilic leukemia</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>meningeal chronic myelogenous leukemia</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>noncontiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II mantle cell lymphoma</keyword>
	<keyword>ovarian choriocarcinoma</keyword>
	<keyword>ovarian embryonal carcinoma</keyword>
	<keyword>ovarian yolk sac tumor</keyword>
	<keyword>ovarian immature teratoma</keyword>
	<keyword>ovarian mature teratoma</keyword>
	<keyword>ovarian monodermal highly specialized teratoma</keyword>
	<keyword>ovarian polyembryoma</keyword>
	<keyword>ovarian mixed germ cell tumor</keyword>
	<keyword>high risk metastatic gestational trophoblastic tumor</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>refractory hairy cell leukemia</keyword>
	<keyword>refractory multiple myeloma</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage III multiple myeloma</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma seminoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor seminoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular teratoma</keyword>
	<keyword>testicular yolk sac tumor teratoma seminoma</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>atypical chronic myeloid leukemia , BCR-ABL1 negative</keyword>
	<keyword>myelodysplastic/myeloproliferative neoplasm , unclassifiable</keyword>
	<keyword>noncontiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>noncontiguous stage II marginal zone lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
</DOC>